Preventing Metastasis of High-Risk Melanoma

Wesley Yu, MD

In the U.S., more than 7,000 people die from melanoma annually. Up to one-third of these deaths are caused by early, localized melanomas (AJCC Stage 1–2) that metastasize despite appropriate surgical treatment. There are no medical treatments designed to prevent early melanoma from progressing to metastatic disease. We are leveraging genetic expression data to discover medications that can halt this metastatic process.

‚— Wesley Yu, M.D.

Related Articles

Crystal Aguh M.D.

Exploring Gene Expression Patterns and Biomarkers of Disease Severity in Central Centrifugal Cicatricial Alopecia

Central centrifugal cicatricial alopecia (CCCA), which has been associated with uterine fibroids, is unlike other scarring alopecias because fibrosis rather…

Read More

Characterizing the Microbiome in Postmenopausal Women with Vulvar Lichen Sclerosus

Vulvar lichen sclerosus is a chronic inflammatory condition that leads to scarring, obliteration of normal vulvar architecture, dyspareunia, and significant…

Read More

Cell Signaling Changes Induced by Surgical Debulking May Improve Response to Smoothened Inhibitor Therapy

Smoothened (SMO) inhibitors, such as vismodegib, are effective treatments for locally advanced basal cell carcinomas (BCCs). However, recurrences are frequent…

Read More